114 related articles for article (PubMed ID: 23339036)
41. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
[TBL] [Abstract][Full Text] [Related]
42. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
Berstein LM; Yue W; Wang JP; Santen RJ
Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
[TBL] [Abstract][Full Text] [Related]
43. Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: behavioral and molecular evidence.
Oliveira DR; Sanada PF; Saragossa Filho AC; Innocenti LR; Oler G; Cerutti JM; Cerutti SM
Brain Res; 2009 May; 1269():68-89. PubMed ID: 19146837
[TBL] [Abstract][Full Text] [Related]
44. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells.
Kang JW; Kim JH; Song K; Kim SH; Yoon JH; Kim KS
Phytother Res; 2010 Jan; 24 Suppl 1():S77-82. PubMed ID: 19585476
[TBL] [Abstract][Full Text] [Related]
45. Heparanase expression correlates with metastatic capability in human choriocarcinoma.
Jingting C; Yangde Z; Yi Z; Huining L; Rong Y; Yu Z
Gynecol Oncol; 2007 Oct; 107(1):22-9. PubMed ID: 17688924
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
[TBL] [Abstract][Full Text] [Related]
47. Ginkgo biloba Extract (EGb 761®) Inhibits Glutamate-induced Up-regulation of Tissue Plasminogen Activator Through Inhibition of c-Fos Translocation in Rat Primary Cortical Neurons.
Cho KS; Lee IM; Sim S; Lee EJ; Gonzales EL; Ryu JH; Cheong JH; Shin CY; Kwon KJ; Han SH
Phytother Res; 2016 Jan; 30(1):58-65. PubMed ID: 26478151
[TBL] [Abstract][Full Text] [Related]
48. Effects of Ginkgo Biloba Extract EGb-761 on Neuropathic Pain in Mice: Involvement of Opioid System.
Zhu C; Li W; Xu F; Li M; Yang L; Hu XY; Ye ZX; Wang Z; Luo ZJ
Phytother Res; 2016 Nov; 30(11):1809-1816. PubMed ID: 27452677
[TBL] [Abstract][Full Text] [Related]
49. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6.
Shozu M; Zhao Y; Bulun SE; Simpson ER
Endocrinology; 1998 Apr; 139(4):1610-7. PubMed ID: 9528941
[TBL] [Abstract][Full Text] [Related]
50. Extract of Ginkgo biloba EGb 761 facilitates fear conditioning measured by fear-potentiated startle.
Yang YL; Su YW; Ng MC; Chang CL; Lu KT
Neurosci Lett; 2005 Jul 22-29; 383(1-2):145-50. PubMed ID: 15936528
[TBL] [Abstract][Full Text] [Related]
51. Common gene targets of Ginkgo biloba extract (EGb 761) in human tumor cells: relation to cell growth.
Li W; Pretner E; Shen L; Drieu K; Papadopoulos V
Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):655-62. PubMed ID: 12396076
[TBL] [Abstract][Full Text] [Related]
52. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000].
Clostre F
Ann Pharm Fr; 1999 Jul; 57 Suppl 1():1S8-88. PubMed ID: 10481350
[TBL] [Abstract][Full Text] [Related]
53. Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761.
Gohil K; Packer L
Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):625-31. PubMed ID: 12396072
[TBL] [Abstract][Full Text] [Related]
54. Phytochemicals for breast cancer prevention by targeting aromatase.
Adams LS; Chen S
Front Biosci (Landmark Ed); 2009 Jan; 14(10):3846-63. PubMed ID: 19273315
[TBL] [Abstract][Full Text] [Related]
55. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
Mouridsen HT
Curr Med Res Opin; 2006 Aug; 22(8):1609-21. PubMed ID: 16870085
[TBL] [Abstract][Full Text] [Related]
56. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Santen RJ
Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
[TBL] [Abstract][Full Text] [Related]
57. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.
Díaz-Cruz ES; Shapiro CL; Brueggemeier RW
J Clin Endocrinol Metab; 2005 May; 90(5):2563-70. PubMed ID: 15687328
[TBL] [Abstract][Full Text] [Related]
58. Trialkyltin compounds enhance human CG secretion and aromatase activity in human placental choriocarcinoma cells.
Nakanishi T; Kohroki J; Suzuki S; Ishizaki J; Hiromori Y; Takasuga S; Itoh N; Watanabe Y; Utoguchi N; Tanaka K
J Clin Endocrinol Metab; 2002 Jun; 87(6):2830-7. PubMed ID: 12050258
[TBL] [Abstract][Full Text] [Related]
59. Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors.
Cepa M; Vaz C
Acta Reumatol Port; 2015; 40(4):323-30. PubMed ID: 26922195
[TBL] [Abstract][Full Text] [Related]
60. Protective effects of ginkgo biloba against acetaminophen-induced toxicity in mice.
Sener G; Omurtag GZ; Sehirli O; Tozan A; Yüksel M; Ercan F; Gedik N
Mol Cell Biochem; 2006 Feb; 283(1-2):39-45. PubMed ID: 16444584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
